A quality lead at a small biotech sends the same peptide reference material to two testing laboratories. One reports 97.8% purity. The other reports 99.1%. Her first instinct is to trust the higher number, or perhaps the laboratory with the nicer report template. A better first question is whether either laboratory demonstrated that its instrument was performing properly on the day the sample was run. That demonstration has a name: system suitability.
A check that runs before the sample does
System suitability testing is a set of measurements made on a known standard, at the start of an analytical sequence and often at intervals within it, before any result on an unknown sample is accepted. The laboratory runs the standard several times and compares the results with acceptance criteria written into the method in advance. If the system fails, the sequence is invalid and no sample results from it are reported.
The reason it exists is simple. On a chromatogram, a poorly performing instrument and a poor sample can look alike. Broad peaks, drifting retention and noisy baselines can come from either. Suitability testing separates the two before anyone starts interpreting the sample.
What the standard runs measure
| Parameter | What it describes | Why it matters for a purity figure |
|---|---|---|
| Retention time repeatability | Whether replicate runs of the standard elute at the same time | Drift points to pump, temperature or mobile-phase problems and undermines peak assignment |
| Peak area precision (%RSD) | Scatter in area across replicate runs | Area is the raw material of area percent; noisy areas mean a noisy purity |
| Theoretical plates | Column efficiency, related to how narrow peaks are | Broad peaks can swallow small neighboring impurities |
| Tailing factor | Peak symmetry | A tailing main peak overlaps what follows it and forces the integrator to guess a boundary |
| Resolution of the critical pair | Separation of the two components the method finds hardest to resolve | If the standard pair is not separated, the sample’s close impurities will not be either |
Methods may add others, such as a signal-to-noise requirement at a reporting threshold, but these five cover the core questions: is the system stable, and can the column still separate?
A degraded system flatters the result
Here is the counter-intuitive part. Area percent purity is the main peak area divided by the total. Anything that hides impurity area under the main peak raises the reported purity. A column that has lost efficiency broadens every peak, and a broadened main peak absorbs the small impurities that elute closest to it. A tailing main peak overlaps whatever elutes just after, and the integrator may assign part of that impurity to the main peak.
So a failing system does not usually produce an obviously bad number. It produces a better-looking one. In the opening scenario, the 99.1% might come from the laboratory with the sharper separation, or it might come from the one whose column could no longer resolve what the other one saw. Without suitability data, the reader cannot tell which. The broader set of reasons two results diverge is discussed in why suppliers report different peptide purity, and how to read an HPLC chromatogram explains what a shoulder on the main peak suggests.
When a report does not mention it
Most analytical reports issued for research peptides do not print suitability data. That is common and not an accusation in itself; a laboratory operating a controlled method will usually have run the checks whether or not they appear on the page the customer sees. It does mean the purity figure arrives without direct evidence that the measurement was under control when it was made.
When the data are shown, two things are worth reading:
- Are acceptance criteria printed beside the measured values? A value with no criterion next to it cannot be judged.
- Do the values sit comfortably inside the criteria? A system that passes by a wide margin is more reassuring than one that just scrapes through.
It is also reasonable to ask a testing laboratory, or a supplier, whether suitability criteria are part of the method used. Our list of HPLC method questions for a peptide supplier includes this and related points. Related pre-run controls, such as solvent blanks to detect residue from earlier runs, belong to the same discipline. For what independent testing does and does not cover more generally, see what third-party tested means.
The limits of the reassurance
Passing system suitability shows the instrument and column were working as the method requires. It does not show that the method was right for this particular compound, that the detection wavelength suited this sequence, that a co-eluting impurity is not hiding under the main peak, or that the sample tested represents the rest of the material. Those are separate questions. A well-controlled measurement of the wrong thing is still a measurement of the wrong thing.
For Battle Born products, Each Battle Born listing shows its own independent reverse-phase HPLC result. Reading that result with an understanding of what suitability testing does and does not guarantee puts the number in its proper context.
Questions
What is HPLC system suitability?
A set of checks on a known standard, run before and during an analytical sequence, confirming that the instrument and column meet predefined performance criteria.
Which parameters are usually checked?
Retention time repeatability, peak area precision, theoretical plates, tailing factor and resolution of a critical pair are the most common.
Why would a worse instrument report higher purity?
Because broad or tailing peaks can hide nearby impurities under the main peak, which raises the area percent.
Does passing suitability prove the purity figure is correct?
No. It proves the system was performing to specification, not that the method suits the compound or that nothing co-elutes.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.